atropine has been researched along with tamsulosin in 16 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (tamsulosin) | Trials (tamsulosin) | Recent Studies (post-2010) (tamsulosin) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 1,460 | 468 | 693 |
| Protein | Taxonomy | atropine (IC50) | tamsulosin (IC50) |
|---|---|---|---|
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.0008 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.0013 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.0045 | |
| Alpha-1D adrenergic receptor | Mus musculus (house mouse) | 0.0018 | |
| Alpha-1B adrenergic receptor | Mus musculus (house mouse) | 0.0018 | |
| Alpha-1A adrenergic receptor | Mus musculus (house mouse) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (50.00) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Bendel, RE; Phillips, MB | 1 |
| Osher, RH | 1 |
| Belani, S; Masket, S | 1 |
| Chang, DF; Koch, DD; Osher, RH; Wang, L | 1 |
| Shugar, JK | 1 |
| Akino, H; Aoki, Y; Ito, H; Miwa, Y; Oyama, N; Yokoyama, O | 1 |
| Al-Ahmar, B; Haridas, A; Hingorani, M; Syrimi, M | 1 |
| Ahmed, RO; Ajomale, K; Mustapha, A; Oladejo, RO; Owoyele, BV | 1 |
| Bulut, AE; Esen, F; Toker, E | 1 |
| Assia, EI; Atar Vardi, M; Eremenko, R; Hecht, I; Pras, E; Safir, M; Sharon, T | 1 |
1 review(s) available for atropine and tamsulosin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 other study(ies) available for atropine and tamsulosin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Preoperative use of atropine to prevent intraoperative floppy-iris syndrome in patients taking tamsulosin.
Topics: Adrenergic alpha-Antagonists; Atropine; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Mydriatics; Ophthalmic Solutions; Phacoemulsification; Preoperative Care; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin | 2006 |
Preoperative atropine in IFIS.
Topics: Adrenergic alpha-Antagonists; Antineoplastic Agents; Atropine; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Mydriatics; Ophthalmic Solutions; Phacoemulsification; Preoperative Care; Prostatic Hyperplasia; Sulfonamides; Syndrome; Tamsulosin | 2007 |
Combined preoperative topical atropine sulfate 1% and intracameral nonpreserved epinephrine hydrochloride 1:4000 [corrected] for management of intraoperative floppy-iris syndrome.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Atropine; Drug Therapy, Combination; Epinephrine; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Mydriatics; Preservatives, Pharmaceutical; Pupil; Sulfonamides; Syndrome; Tamsulosin | 2007 |
Prospective multicenter evaluation of cataract surgery in patients taking tamsulosin (Flomax).
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Atropine; Eye Color; Humans; Incidence; Intraoperative Complications; Iris Diseases; Lens Implantation, Intraocular; Male; Phacoemulsification; Postoperative Complications; Prospective Studies; Sulfonamides; Syndrome; Tamsulosin; Treatment Outcome; Visual Acuity | 2007 |
Prophylaxis for IFIS.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Atropine; Cataract Extraction; Drug Therapy, Combination; Epinephrine; Humans; Intraoperative Complications; Iris; Iris Diseases; Male; Mydriatics; Preservatives, Pharmaceutical; Prostatic Hyperplasia; Pupil; Sulfonamides; Syndrome; Tamsulosin | 2007 |
Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
Topics: Administration, Intravesical; Administration, Topical; Adrenergic alpha-Antagonists; Animals; Atropine; Benzilates; Calcium Channel Blockers; Cholinergic Antagonists; Dinoprostone; Disease Models, Animal; Female; Injections, Intra-Arterial; Muscarinic Antagonists; Muscle Contraction; omega-Conotoxins; Oxytocics; Pressure; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin; Treatment Outcome; Urethra; Urinary Bladder; Urinary Bladder, Overactive; Verapamil | 2007 |
Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates.
Topics: Adrenergic alpha-1 Receptor Antagonists; Atropine; Doxazosin; Drug Therapy, Combination; Female; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Mydriatics; Phacoemulsification; Phenylephrine; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin; United Kingdom | 2013 |
Analgesic and anti-inflammatory effects of honey: the involvement of autonomic receptors.
Topics: Adrenergic Antagonists; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Autonomic Nervous System; Carrageenan; Cholinergic Antagonists; Drug Evaluation, Preclinical; Drug Therapy, Combination; Edema; Formaldehyde; Hexamethonium; Honey; Hot Temperature; Indomethacin; Male; Pain Perception; Propranolol; Rats; Sulfonamides; Tamsulosin | 2014 |
Efficacy and safety of low-concentration, bisulphite-containing, intracameral epinephrine and topical atropine treatments for the prevention of intraoperative floppy iris syndrome.
Topics: Administration, Ophthalmic; Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Atropine; Epinephrine; Follow-Up Studies; Humans; Incidence; Injections, Intraocular; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Phacoemulsification; Preoperative Care; Preservatives, Pharmaceutical; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfites; Sulfonamides; Tamsulosin; Treatment Outcome | 2018 |
Preoperative atropine and non-steroidal anti-inflammatory drugs for the prevention of intraoperative floppy iris syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Atropine; Humans; Incidence; Intraoperative Complications; Iris; Iris Diseases; Male; Phacoemulsification; Pharmaceutical Preparations; Retrospective Studies; Sulfonamides; Tamsulosin | 2022 |